WO2002072567A3 - Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them - Google Patents

Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them Download PDF

Info

Publication number
WO2002072567A3
WO2002072567A3 PCT/US2002/007315 US0207315W WO02072567A3 WO 2002072567 A3 WO2002072567 A3 WO 2002072567A3 US 0207315 W US0207315 W US 0207315W WO 02072567 A3 WO02072567 A3 WO 02072567A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
heterocyclic compounds
compound
Prior art date
Application number
PCT/US2002/007315
Other languages
French (fr)
Other versions
WO2002072567A2 (en
Inventor
Duvvuri Subrahmanyam
Sunil Vasantrao Mali
Gopalan Balasubramanian
Aftab Dawoodbhai Lakdawala
Original Assignee
Glenmark Pharmaceuticals Ltd
Mass Clifford J
Duvvuri Subrahmanyam
Sunil Vasantrao Mali
Gopalan Balasubramanian
Aftab Dawoodbhai Lakdawala
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd, Mass Clifford J, Duvvuri Subrahmanyam, Sunil Vasantrao Mali, Gopalan Balasubramanian, Aftab Dawoodbhai Lakdawala filed Critical Glenmark Pharmaceuticals Ltd
Priority to AU2002306687A priority Critical patent/AU2002306687A1/en
Publication of WO2002072567A2 publication Critical patent/WO2002072567A2/en
Publication of WO2002072567A3 publication Critical patent/WO2002072567A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

A compound of the general formula (I) and method for preparing and using the compound of formula (I).
PCT/US2002/007315 2001-03-13 2002-03-12 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them WO2002072567A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002306687A AU2002306687A1 (en) 2001-03-13 2002-03-12 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN240/MUM/2001 2001-03-13
IN240MU2001 2001-03-13

Publications (2)

Publication Number Publication Date
WO2002072567A2 WO2002072567A2 (en) 2002-09-19
WO2002072567A3 true WO2002072567A3 (en) 2002-11-28

Family

ID=11097228

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/007315 WO2002072567A2 (en) 2001-03-13 2002-03-12 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them

Country Status (2)

Country Link
AU (1) AU2002306687A1 (en)
WO (1) WO2002072567A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0314721A (en) * 2002-10-23 2005-08-02 Glenmark Pharmaceuticals Ltd Tricyclic compounds useful for treating inflammatory and allergic disorders, processes for their preparation and pharmaceutical compositions containing them
WO2004069831A1 (en) * 2003-02-10 2004-08-19 Glenmark Pharmaceuticals Ltd. Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation
DE602004020332D1 (en) 2003-04-11 2009-05-14 Glenmark Pharmaceuticals Sa NEW HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISEASES: METHOD OF PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO2004111044A1 (en) * 2003-06-17 2004-12-23 Glenmark Pharmaceuticals Ltd. Tricyclic compounds useful for the treatment of inflammatory and allergic disorders:process for their preparation
EP1799632A2 (en) 2004-10-13 2007-06-27 Glenmark Pharmaceuticals S.A. Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide
MX2007007345A (en) 2004-12-17 2007-09-07 Glenmark Pharmaceuticals Sa Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders.
SI1831227T1 (en) 2004-12-17 2013-09-30 Glenmark Pharmaceuticals S.A. Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
TW201711999A (en) 2015-09-03 2017-04-01 佛瑪治療公司 [6,6] fused bicyclic HDAC8 inhibitors
GB201801130D0 (en) 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1193637A (en) * 1957-01-08 1959-11-04 Rhone Poulenc Sa New acyl and amine derivatives of benzodioxane
US3157674A (en) * 1963-04-30 1964-11-17 Ciba Geigy Corp 2-(cycloaliphatic-alkyl-aminomethyl)-benzodioxanes
DE1518042A1 (en) * 1965-11-11 1969-06-12 Merck Ag E Process for the preparation of 1,4-benzodioxane derivatives
DE2840454A1 (en) * 1978-09-16 1980-04-03 Madaus & Co Dr 3,4-Di:hydroxy-cinnamaldehyde dimer - is anti-hepato:toxic agent obtd. by treating the acetone isolation prod. of Phytolacca fruits with alkali
GB2046259A (en) * 1979-03-20 1980-11-12 Kyowa Hakko Kogyo Kk Amino-alcohol derivatives and pharmaceutical compositions containing them
WO1992018494A1 (en) * 1991-04-19 1992-10-29 Ciba-Geigy Ag Methyl esters of aldimino- or ketimino-oxy-orthotolylacrylic acid, manufacturing process and fungicides containing them

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1193637A (en) * 1957-01-08 1959-11-04 Rhone Poulenc Sa New acyl and amine derivatives of benzodioxane
US3157674A (en) * 1963-04-30 1964-11-17 Ciba Geigy Corp 2-(cycloaliphatic-alkyl-aminomethyl)-benzodioxanes
DE1518042A1 (en) * 1965-11-11 1969-06-12 Merck Ag E Process for the preparation of 1,4-benzodioxane derivatives
DE2840454A1 (en) * 1978-09-16 1980-04-03 Madaus & Co Dr 3,4-Di:hydroxy-cinnamaldehyde dimer - is anti-hepato:toxic agent obtd. by treating the acetone isolation prod. of Phytolacca fruits with alkali
GB2046259A (en) * 1979-03-20 1980-11-12 Kyowa Hakko Kogyo Kk Amino-alcohol derivatives and pharmaceutical compositions containing them
WO1992018494A1 (en) * 1991-04-19 1992-10-29 Ciba-Geigy Ag Methyl esters of aldimino- or ketimino-oxy-orthotolylacrylic acid, manufacturing process and fungicides containing them

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALEJANDRA G. SUAREZ: "ALCL3-DMA REAGENT", TETRAHEDRON LETTERS., vol. 40, 1999, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM., NL, pages 3523 - 6, XP004162326, ISSN: 0040-4039 *
V. THIÉRY ET AL.: "CONVENIENT SYNTHESIS OF 2-SUBST. 6- OR 7-ACYLATED 1,4-BENZODIOXIN", TETRAHEDRON., vol. 51, no. 9, 1995, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM., NL, pages 2619 - 28, XP002214666, ISSN: 0040-4020 *

Also Published As

Publication number Publication date
AU2002306687A1 (en) 2002-09-24
WO2002072567A2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
WO2002048147A3 (en) Pyrazolopyridines
HK1050526A1 (en) New a-amino acid compounds, a process for their preparation and pharmaceutical compositions containing them.
WO2004074244A3 (en) Pyrimidine compounds
WO2001029055A3 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
WO2002048148A3 (en) Pyrazolopyridine derivatives
WO2003018553A8 (en) Oral antidiabetic agents
WO2004093800A3 (en) Thyronamine derivatives and analogs and methods of use thereof
GB0109122D0 (en) Novel compounds
RS11304A (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
CA2494321A1 (en) 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
WO2004026267A3 (en) Tri(alkylcarboxylato) gallium (iii) products and pharmaceutical compositions containing them
WO2002072567A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
WO2003054001A3 (en) Method for preparing echinocandin derivatives and their compositions
WO2003047505A3 (en) Topoisomerase poison agents
WO2006006040A3 (en) News diamine salts of cephalosporin antibiotics and their preparation
AU2003231920A1 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
WO2000046210A3 (en) New process for preparing pesticidal intermediates
WO2003080631A8 (en) Plasma carboxypeptidase b inhibitors
AU2002248531A1 (en) Pyrazolopyriadine derivatives
AU2002313065A1 (en) Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
WO2000059862A3 (en) Processes for preparing pesticidal intermediates
AU2002210632A1 (en) Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
AU2003252467A1 (en) Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
WO2005056563A3 (en) Process for the preparation of thiazolopyrimidines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP